|
My ExpertiseMy Expertise
Area(s) of expertise:
Epilepsy, Neuroscience, PTSD
Summary of expertise:
Christopher DeGiorgio, M.D., is the Vice President of Neurosigma, a leading medical device company engaged in cutting-edge research and clinical trials for the treatments of epilepsy, depression, post-traumatic stress disorder (PTSD), and obesity. Dr. DeGiorgio is also a Professor at the UCLA School of Medicine’s Department of Neurology, where he has served as the Vice-Chairman of the Department. DeGiorgio engineered the development of Trigeminal Nerve Stimulation (TNS), a novel and non-invasive therapy for epilepsy. DeGiorgio received a BS in Biology at Loyola Marymount University and an MD from Loyola University Chicago School of Medicine. |
Comments